Abiopharma

🔍 Brockman Dawn M. (Executive)

Company: AMERIPRISE FINANCIAL INC (AMP)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 472 shares of Common Stock at $558.9301 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 713.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 146.79 | Footnotes: F1

Footnotes:

• F1: Estimate of the number of shares held in the reporting person's account in the Ameriprise Financial Stock Fund under the Ameriprise Financial 401(k) plan as of August 10, 2026. This plan uses unit accounting and the number of shares that a participant is deemed to hold varies with the price of Ameriprise stock.